FDA-NIH biomarker working group, BEST (Biomarkers, EndpointS, and other Tools) resource, Silver Spring (MD): Food and Drug Administration
Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Lipid Accumulation Researchers reported reduced lipid accumulation during selected adipocyte-differentiation and lipogenesis experiments
Peptide Combinations: What the Current Evidence Shows Potential Risks and Safety Concerns of Stacking Peptides Regulatory Status of Retatrutide and Related Peptides in the UK Speaking to a Healthcare Professional Before Combining Peptides Safer, Evidence-Based Alternatives Available Through the NHS Scientific References Frequently Asked Questions What Is Retatrutide and How Does It Work
Liposomal Glutathione Liquid by Pure Encapsulations